Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Systematic genomic screen for tyrosine kinase mutations in CLL.

Brown JR, Levine RL, Thompson C, Basile G, Gilliland DG, Freedman AS.

Leukemia. 2008 Oct;22(10):1966-9. doi: 10.1038/leu.2008.222. Epub 2008 Aug 28. No abstract available.

PMID:
18754031
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.

Schroers R, Griesinger F, Trümper L, Haase D, Kulle B, Klein-Hitpass L, Sellmann L, Dührsen U, Dürig J.

Leukemia. 2005 May;19(5):750-8.

PMID:
15759031
[PubMed - indexed for MEDLINE]
3.

Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.

Lehmann S, Ogawa S, Raynaud SD, Sanada M, Nannya Y, Ticchioni M, Bastard C, Kawamata N, Koeffler HP.

Cancer. 2008 Mar 15;112(6):1296-305. doi: 10.1002/cncr.23270.

PMID:
18246537
[PubMed - indexed for MEDLINE]
Free Article
4.

The study of different chromosomal aberrations, CD38 and ZAP-70 in chronic lymphocytic leukemia patients.

Hassab AH, Elbordiny MM, Elghandour AH, Sorour AF, Swelem RS.

Egypt J Immunol. 2011;18(2):77-93.

PMID:
23082473
[PubMed - indexed for MEDLINE]
5.

Comparison of ZAP-70/Syk mRNA levels with immunoglobulin heavy-chain gene mutation status and disease progression in chronic lymphocytic leukemia.

Laurenti L, Petlickovski A, Rumi C, Gobessi S, Piccioni P, Tarnani M, Puggioni P, Marietti S, Sica S, Leone G, Efremov DG.

Haematologica. 2005 Nov;90(11):1533-40.

PMID:
16266901
[PubMed - indexed for MEDLINE]
Free Article
6.

Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.

Kröber A, Bloehdorn J, Hafner S, Bühler A, Seiler T, Kienle D, Winkler D, Bangerter M, Schlenk RF, Benner A, Lichter P, Döhner H, Stilgenbauer S.

J Clin Oncol. 2006 Feb 20;24(6):969-75. Epub 2006 Jan 17.

PMID:
16418492
[PubMed - indexed for MEDLINE]
7.

High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature.

Janssens A, Van Roy N, Poppe B, Noens L, Philippé J, Speleman F, Offner F.

Eur J Haematol. 2012 Jul;89(1):72-80. doi: 10.1111/j.1600-0609.2012.01790.x. Epub 2012 May 7.

PMID:
22509718
[PubMed - indexed for MEDLINE]
8.

B-cell chronic lymphocytic leukemia with aberrant CD8 expression: genetic and immunophenotypic analysis of prognostic factors.

Schroers R, Pukrop T, Dürig J, Haase D, Dührsen U, Trümper L, Griesinger F.

Leuk Lymphoma. 2004 Aug;45(8):1677-81.

PMID:
15370224
[PubMed - indexed for MEDLINE]
9.

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.

Wiestner A, Rosenwald A, Barry TS, Wright G, Davis RE, Henrickson SE, Zhao H, Ibbotson RE, Orchard JA, Davis Z, Stetler-Stevenson M, Raffeld M, Arthur DC, Marti GE, Wilson WH, Hamblin TJ, Oscier DG, Staudt LM.

Blood. 2003 Jun 15;101(12):4944-51. Epub 2003 Feb 20.

PMID:
12595313
[PubMed - indexed for MEDLINE]
Free Article
10.

11q22.3 deletion in B-chronic lymphocytic leukemia is specifically associated with bulky lymphadenopathy and ZAP-70 expression but not reduced expression of adhesion/cell surface receptor molecules.

Dickinson JD, Gilmore J, Iqbal J, Sanger W, Lynch JC, Chan J, Bierman PJ, Joshi SS.

Leuk Lymphoma. 2006 Feb;47(2):231-44.

PMID:
16321852
[PubMed - indexed for MEDLINE]
11.

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, Marcé S, López-Guillermo A, Campo E, Montserrat E.

N Engl J Med. 2003 May 1;348(18):1764-75.

PMID:
12724482
[PubMed - indexed for MEDLINE]
Free Article
12.

Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia.

Boelens J, Lust S, Van Bockstaele F, Van Gele M, Janssens A, Derycke L, Vanhoecke B, Philippé J, Bracke M, Offner F.

Leuk Res. 2009 Oct;33(10):1335-43. doi: 10.1016/j.leukres.2009.02.022. Epub 2009 Mar 17.

PMID:
19297020
[PubMed - indexed for MEDLINE]
13.

Clonal evolution in chronic lymphocytic leukemia studied by interphase fluorescence in-situ hybridization.

Berkova A, Zemanova Z, Trneny M, Schwarz J, Karban J, Cmunt E, Pavlistova L, Brezinova J, Michalova K.

Neoplasma. 2009;56(5):455-8.

PMID:
19580349
[PubMed - indexed for MEDLINE]
14.

Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH status.

Kim SZ, Chow KU, Kukoc-Zivojnov N, Boehrer S, Brieger A, Steimle-Grauer SA, Harder L, Hoelzer D, Mitrou PS, Weidmann E.

Leuk Lymphoma. 2004 Oct;45(10):2037-45.

PMID:
15370248
[PubMed - indexed for MEDLINE]
15.

Chromosome abnormalities with prognostic impact in B-cell chronic lymphocytic leukemia.

Méhes G.

Pathol Oncol Res. 2005;11(4):205-10. Epub 2005 Dec 31. Review.

PMID:
16388316
[PubMed - indexed for MEDLINE]
Free Article
16.

SYK carries no activating point mutations in patients with chronic lymphocytic leukaemia (CLL).

Philippen A, Diener S, Zenz T, Döhner H, Stilgenbauer S, Mertens D.

Br J Haematol. 2010 Sep;150(5):633-6. doi: 10.1111/j.1365-2141.2010.08244.x. Epub 2010 May 26. No abstract available.

PMID:
20528870
[PubMed - indexed for MEDLINE]
17.

Polymorphisms and haplotypes in multidrug resistance 1 gene are not associated with chronic lymphocytic leukemia susceptibility and prognostic parameters of chronic lymphocytic leukemia in Chinese population.

Dong HJ, Miao KR, Qiao C, Zhuang Y, Shen WY, Hong M, Fan L, Liu P, Xu W, Li JY.

Leuk Lymphoma. 2011 Jun;52(6):1003-9. doi: 10.3109/10428194.2011.557454. Epub 2011 Apr 4.

PMID:
21463115
[PubMed - indexed for MEDLINE]
18.

IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL).

Del Giudice I, Davis Z, Matutes E, Osuji N, Parry-Jones N, Morilla A, Brito-Babapulle V, Oscier D, Catovsky D.

Leukemia. 2006 Jul;20(7):1231-7. Epub 2006 Apr 27.

PMID:
16642047
[PubMed - indexed for MEDLINE]
19.

Most morphologic features in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) do not reliably predict underlying FISH genetics or immunoglobulin heavy chain variable region somatic mutational status.

Garcia CF, Hunt KE, Kang H, Babb A, Gale JM, Vasef MA, Reichard KK.

Appl Immunohistochem Mol Morphol. 2010 Mar;18(2):119-27. doi: 10.1097/PAI.0b013e3181bbd5d5.

PMID:
19826250
[PubMed - indexed for MEDLINE]
20.

Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia.

Chen L, Zhang Y, Zheng W, Wu Y, Qiao C, Fan L, Xu W, Li J.

Leuk Res. 2008 Oct;32(10):1491-8. doi: 10.1016/j.leukres.2008.02.005. Epub 2008 Mar 21.

PMID:
18359082
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk